American Pharma Group says IP Protection in India is Weak

Tuesday, February 9, 2016

Source: FiercePharmaAsia

The Pharmaceutical Research and Manufacturers of America (PhRMA), one of the top bodies representing American pharmaceutical and biotechnology companies, said in an annual report that India's intellectual property rights protection is weak and the group added India to its "priority watch list."

The country's legal and regulatory systems "pose procedural and substantive barriers at every step of the patents process," the group said, according to a report by Livemint.

View All News »